| Sorafenib |
Influence on cell viability |
MTT |
N/A µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell viability |
MTT |
N/A µM |
LN229 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell viability |
MTT |
N/A µM |
AS515 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell viability |
MTT |
N/A µM |
U251 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell viability |
MTT |
N/A µM |
GS620 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell viability |
MTT |
N/A µM |
GS48 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell cycle |
Flow cytometry |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell cycle |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell cycle |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell cycle |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell cycle |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
7.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
15.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
7.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
15.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
p-STAT3(Y705) |
|
| Sorafenib |
Influence on protein activity |
Western Blot |
7.00 µM |
U87 |
Homo sapiens |
|
p-STAT3(Y705) |
|
| Sorafenib |
Influence on protein activity |
Western Blot |
15.00 µM |
U87 |
Homo sapiens |
|
p-STAT3(Y705) |
|
| Sorafenib |
Influence on protein activity |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
STAT3 |
|
| Sorafenib |
Influence on protein activity |
Western Blot |
7.00 µM |
U87 |
Homo sapiens |
|
STAT3 |
|
| Sorafenib |
Influence on protein activity |
Western Blot |
15.00 µM |
U87 |
Homo sapiens |
|
STAT3 |
|
| Sorafenib |
Influence on protein activity |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
7.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
15.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
7.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
15.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
7.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
15.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
7.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
15.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
7.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
15.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
7.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on protein activity |
Western Blot |
15.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell viability |
Trypan Blue staining |
N/A µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell viability |
Trypan Blue staining |
N/A µM |
LN229 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell viability in transfected cells |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell viability in transfected cells |
Western Blot |
7.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell viability in transfected cells |
Western Blot |
15.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell viability in transfected cells |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell viability in transfected cells |
Western Blot |
7.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell viability in transfected cells |
Western Blot |
15.00 µM |
U87 |
Homo sapiens |
|
|
|
| Sorafenib |
Influence on cell viability in transfected cells |
Western Blot |
3.00 µM |
U87 |
Homo sapiens |
|
|
|
